Martingale Asset Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Martingale Asset Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-17,400	Closed	-$290K	–	1050
2019 Q3	$290K	Sell	17,400 -149,312	-90%	-$2.06M	﹤0.01%	939
2019 Q2	$2.29M	Buy	166,712 +1,200	+0.7%	+$18.4K	0.02%	559
2019 Q1	$2.85M	Buy	165,512 +48,300	+41%	+$764K	0.03%	507
2018 Q4	$1.5M	Buy	+117,212	New	+$1.78M	0.02%	611

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Martingale Asset Management's OXFD Position: Q4 2019 in Review

Martingale Asset Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2019, closing a stake of 17,400 shares — an estimated $290K sold.

Martingale Asset Management first reported a position in OXFD in Q4 2018 and held it in 4 quarters. The position peaked at $2.85M in Q1 2019. 68 funds tracked by Wall St. Rank hold OXFD as of Q4 2019.

Martingale Asset Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2019 after selling out during the quarter.
Martingale Asset Management sold 17,400 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2019, an estimated $290K.
Martingale Asset Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2018 and held it in 4 quarters.
Martingale Asset Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $2.85M in Q1 2019.
68 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2019.

Based on Martingale Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.